Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Blood|March 29, 2013
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialHong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, et al.Blood Cancer Journal|November 20, 2022
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)Huai-Yu Wang, Sha Gong, Guo-Hui Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.Haematologica|November 13, 2025
The comprehensive landscape of TTMV::RARA fusion-driven acute myeloid leukemia: from viral integration mechanisms to clinical outcomesShu Sun, Yongjing Liu, Qing-Yu Xu, et al.Journal of Hematology & Oncology|October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemiaYa-Fang Ma, Ying Lu, Qian Wu, et al.Cancer Medicine|June 4, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort studyJie-Jing Qian, Xiaoxia Hu, Ying Wang, et al.British Journal of Haematology|July 12, 2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trialMixue Xie, Ying Lu, Guifang Ouyang, et al.Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemiaWen-Yan Cheng, Jian-Feng Li, Yong-Mei Zhu, et al.Blood|July 24, 2024
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APLXiaosu Zhou, Xue Chen, Jiaqi Chen, et al.Blood Cancer Discovery|October 18, 2021
Hyperthermia Selectively Destabilizes Oncogenic Fusion ProteinsYasen Maimaitiyiming, Qian Qian Wang, Chang Yang, et al.Pageof 13